A pilot study on the use of interferon beta-1a in early Alzheimer’s disease subjects

Despite the fact that multiple sclerosis (MS) and Alzheimer’s disease (AD) share common neuroimmunological features, interferon beta 1a (IFNβ1a), the well-established treatment for the prevention of disease progression and cognitive decline in MS patients, has never been used in AD. We evaluated the...

Descripción completa

Detalles Bibliográficos
Autores principales: Grimaldi, Luigi Maria Edoardo, Zappalà, Giuseppe, Iemolo, Francesco, Castellano, Anna Elisa, Ruggieri, Stefano, Bruno, Giuseppe, Paolillo, Andrea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3931325/
https://www.ncbi.nlm.nih.gov/pubmed/24524367
http://dx.doi.org/10.1186/1742-2094-11-30

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3931325/
https://www.ncbi.nlm.nih.gov/pubmed/24524367
http://dx.doi.org/10.1186/1742-2094-11-30

Ejemplares similares